Catalyst Capital Advisors’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-29
Closed -$7K 536
2018
Q2
$7K Buy
+29
New +$7K ﹤0.01% 378